Restenosis in the coronary stent is an argument for the surgical myocardial revascularization

Insights

Coronary artery bypass grafting (CABG) showed a lower restenosis rate than percutaneous coronary intervention (PCI) using stents in patients with multivessel coronary disease. This finding is notable as drug-eluting stents were not widely used in this study.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) management often involves revascularization procedures.
  • Percutaneous coronary intervention (PCI) with stents and Coronary Artery Bypass Grafting (CABG) are primary treatment options.
  • Evaluating restenosis rates is crucial for long-term patient outcomes.

Purpose of the Study:

  • To compare the frequency of restenosis between PCI (stents) and CABG.
  • To assess restenosis rates based on clinical criteria (angina recurrence).
  • To provide insights into the effectiveness of different revascularization strategies.

Main Methods:

  • Retrospective analysis of 6564 coronarographies (1999-2002).
  • Included 3110 patients undergoing myocardial revascularization (PCI or CABG).
  • Angiographic follow-up was performed on 105 patients (55 PCI, 50 CABG) based on clinical recurrence of angina.

Main Results:

  • Restenosis occurred in 47 patients (74.5%) treated with stents and 29 patients after CABG.
  • The overall restenosis rate was 4.8% for PCI and 2.5% for CABG.
  • CABG demonstrated a lower restenosis rate compared to PCI in this cohort.

Conclusions:

  • Both CABG and PCI are effective for multivessel coronary disease.
  • CABG showed a lower restenosis rate than PCI, particularly in the absence of widespread drug-eluting stent (DES) use.
  • The advent of DES may alter restenosis rates in PCI, highlighting a complex interplay of factors in restenosis prevention.
Abstract